APPROVALS

U.S. FDA approves Alvotech and Teva’s SELARSDI, biosimilar to Stelara

The U.S. Food and Drug Administration (FDA) has approved Alvotech and Teva Pharmaceuticals' SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Beckman Coulter’s DxI 9000 Immunoassay Analyzer extends menu with new CE-marked hepatitis assays at ESCMID Global

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases...

Getinge and CellRev launch pioneering adherent cell expansion platform

CellRev, in partnership with Getinge, has launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated...

Data on over 2,300 lung cancer biomarkers mapped in new global database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year

ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, is delighted to announce that for the fourth consecutive year, it...

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (Menarini) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United...

Approvals

Manufacturiung

Finance

Research & Development
Latest

R&D

Medincell enters into agreement with AbbVie to develop next-generation long-acting injectable therapies

Medincell has formed a collaboration with AbbVie to co-develop and commercialize up to six therapeutic products across multiple therapeutic areas and indications. It will use...
R&D

Mundipharma and Vectura announce plans to reformulate flutiform® pressurised metered-dose inhaler as a commitment to reducing the product’s carbon footprint

Mundipharma and Vectura will now progress development of the reformulation of flutiform® (fluticasone propionate/formoterol fumarate) following long-term collaboration, planning and lab-scale development work. The...
R&D

Candel Therapeutics receives FDA Orphan Drug Designation for pancreatic cancer treatment

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to CAN-2409, Candel Therapeutics' most advanced multimodal biological immunotherapy candidate, for the...
R&D

Rallybio collaborates with Johnson & Johnson to advance therapies for fetal and neonatal alloimmune thrombocytopenia

Rallybio has announced a collaboration with Johnson & Johnson to support the development of complementary therapeutic approaches aimed at reducing the risk of fetal...
R&D

Lisata Therapeutics gains U.S. FDA Orphan Drug Designation for osteosarcoma treatment

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to LSTA1, Lisata Therapeutics’ lead product candidate for the treatment of...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks